Standardising lipid testing and reporting in the United Kingdom; a joint statement by HEART UK and The Association

Julia S Kenkre1,2, Tina Mazaheri1,2, R Dermot G Neely3,4

  • 1Department of Clinical Biochemistry, Imperial College Healthcare NHS Trust, Charing Cross Hospital, London, UK.

PubMed

Insights

New UK guidelines offer evidence-based lipid testing recommendations for laboratories and clinicians to assess cardiovascular risk. This aims to improve management of atherosclerotic cardiovascular disease, a leading cause of premature death.

Area of Science:

  • Cardiovascular Medicine
  • Clinical Biochemistry
  • Public Health

Background:

  • Atherosclerotic cardiovascular disease is a leading cause of premature mortality in the UK.
  • Lipid testing is crucial for cardiovascular risk assessment and clinical decision-making.
  • Existing national guidelines for lipid testing and reporting in the UK are lacking.

Purpose of the Study:

  • To establish consensus-based, evidence-driven guidelines for lipid testing and reporting in the UK.
  • To provide recommendations for standard and enhanced lipid profiles.
  • To guide laboratories and clinicians in interpreting and reporting lipid test results.

Main Methods:

  • A multidisciplinary group of UK experts reviewed published evidence.
  • Consensus was reached on key aspects of lipid testing and reporting.
  • Guidance was developed for standard and enhanced lipid profiles, including specific analytes and calculations.

Main Results:

  • Recommendations cover the composition of standard and enhanced lipid profiles.
  • Specific guidance is provided for including apolipoprotein B and lipoprotein (a).
  • The Sampson-NIH calculation for LDL-c estimation and criteria for flagging abnormal results are recommended.

Conclusions:

  • The consensus guidance provides a framework for consistent lipid testing and reporting across the UK.
  • Implementation of these guidelines can enhance cardiovascular risk assessment and patient management.
  • The guidance is endorsed by HEART UK and The Association for Laboratory Medicine.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Overview of Lipid Metabolism01:24

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...